Skip to main content
Clinical Trials/NCT02259335
NCT02259335
Unknown
Not Applicable

A Pilot Study on the Use of Extracorporeal CO2 Removal During the Weaning Process From Mechanical Ventilation

IRCCS Azienda Ospedaliero-Universitaria di Bologna2 sites in 1 country15 target enrollmentOctober 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients With Acute Hypercapnic Respiratory Failure
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
15
Locations
2
Primary Endpoint
passing a weaning trial using a T-piece method
Last Updated
9 years ago

Overview

Brief Summary

Weaning from invasive mechanical ventilation is one of the major clinical problem especially ion those patients with a pre-existing chronic respiratory disease and chronic hypercpania.

The aim of this pilot feasibility and safety trial is to assess the possibility of shorten the duration of mechanical ventilation using a device able to remove CO2 and theoretically able to allow therefore the praecox extubation

Detailed Description

Weaning from invasive mechanical ventilation is one of the major clinical problem especially ion those patients with a pre-existing chronic respiratory disease and chronic hypercpania. Up to 60% of the ventilatory time is devoted in these patients to the process of weaning. These patients very often fail several weaning attempt, when a T-piece trial method is used. In this case they are also very likely to require tracheotomy. In this study we will enroll those still hypercapnic patients fitting the criteria of readiness to be wean (i.e. clinical stability, normal sensorium and good cough reflex) and failing a T-piece trail because of a rise in PaCO2 (\>20% from baseline) and/or a rapid shallow breathing index (f/VT)\> 100. After the unsuccessful trial they will be reconnected to the ventilator and they will repeat hours later the same T-piece trial once the extracorporeal CO2 removal device (DeCap) will be connected via a double lumen catheter in the femoral vein. The investigators aim to verify whether using the DeCap) the investigators will be able to avoid at the end of the T-piece trial the criteria of failure. If so, the patient will be extubated and DeCap will be continued when all of the following were achieved for at least 12 hours: respiratory rate less than 25 breaths/min; pH greater than 7.35; Paco2 less than 20% of the baseline value; and absence of use of the accessory muscles or paradoxical abdominal movements.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
October 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

dr. Stefano Nava

Professor of Respiratory Medicine

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility Criteria

Inclusion Criteria

  • Patients meeting the criteria for readiness to be weaned (i.e. clinical stability, FiO2\<50%, normal sensorium, body temperature \< 38 and satisfactory cough reflex)
  • Failing a T-piece trial after 1 hour or before for a rise in PaCO2\>20% from baseline and with f/VT ratio \>100

Exclusion Criteria

  • Patients NOT meeting the criteria for readiness to be weaned
  • Patients succeeding a T-piece trial

Outcomes

Primary Outcomes

passing a weaning trial using a T-piece method

Time Frame: 1 hour

avoiding to reach the criteria of weaning failure

weaning success

Time Frame: 48 hours

avoiding reintubation after removal of DeCap

Secondary Outcomes

  • Physiological variables (i.e. Arterial Blood Gases, vitals and dyspnea)(48 hours)

Study Sites (2)

Loading locations...

Similar Trials